Severe acute respiratory syndrome coronavirus pathogenesis, disease and vaccines: An update

Pediatric Infectious Disease Journal

Volumn 23, Issue 11 SUPPL., 2004, Pages

  Denison, Mark R ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Animal models; Attenuation; Children; Coronavirus; Live attenuated vaccines; Mouse hepatitis virus; Replicase proteins; Replication; Reverse genetics; Severe acute respiratory syndrome

Indexed keywords

ANAMNESIS; CONFERENCE PAPER; CONTROLLED STUDY; HUMAN; PATHOGENESIS; PATHOLOGY; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; VIRUS REPLICATION; VIRUS STRAIN; ADOLESCENT; ADULT; AGE; ANIMAL; CHILD; DISEASE MODEL; DISEASE TRANSMISSION; EPIDEMIC; HOSPITALIZATION; IMMUNOLOGY; PATHOGENICITY; PATHOPHYSIOLOGY; REVIEW; ZOONOSIS;

VIRUS ANTIBODY; VIRUS VACCINE;

ADOLESCENT; ADULT; AGE FACTORS; ANIMALS; ANTIBODIES, VIRAL; CHILD; DISEASE MODELS, ANIMAL; DISEASE OUTBREAKS; HUMANS; SARS VIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; SEVERITY OF ILLNESS INDEX; VIRAL VACCINES; ZOONOSES;

EID: 16544392193     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000144666.95284.05     Document Type: Conference Paper

References (43)

1. Booth CM, Matukas LM, Tomlinson GA, et al. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA. 2003;289:2801-2809.
2. Chan TY, Miu KY, Tsui CK, Yee KS, Chan MH. A comparative study of clinical features and outcomes in young and older adults with severe acute respiratory syndrome. J Am Geriatr Soc. 2004;52:1321-1325.
3. Chen SY, Chiang WC, Ma MH, et al. Sequential symptomatic analysis in probable severe acute respiratory syndrome cases. Ann Emerg Med. 2004;43:27-33.
4. Cheng VC, Hung IF, Tang BS, et al. Viral replication in the nasopharynx is associated with diarrhea in patients with severe acute respiratory syndrome. Clin Infect Dis. 2004;38:467-475.
5. Choi KW, Chau TN, Tsang O, et al. Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong. Ann Intern Med. 2003;139:715-723.
6. Hui DS, Wong PC, Wang C. SARS: clinical features and diagnosis. Respirology. 2003;8(suppl):S20-S24.
7. Jang TN, Yeh DY, Shen SH, Huang CH, Jiang JS, Kao SJ. Severe acute respiratory syndrome in Taiwan: analysis of epidemiological characteristics in 29 cases. J Infect. 2004;48:23-31.
8. Peiris JS, Lai ST, Poon LL, et al. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet. 2003;361:1319-1325.
9. Van Der Hoek L, Pyre K, Jebbink MF, et al. Identification of a new human coronavirus. Nat Med. 2004;10:368-373.
10. Wang JT, Sheng WH, Fang CT, et al. Clinical manifestations, laboratory findings, and treatment outcomes of SARS patients Emerg Infect Dis. 2004;10:818-824.
11. Bitnun A, Allen U, Heurter H, et al. Children hospitalized with severe acute respiratory syndrome-related illness in Toronto Pediatrics 2003; 112:e261.
12. Chiu WK, Cheung PC, Ng KL, et al. Severe acute respiratory syndrome in children: experience in a regional hospital in Hong Kong. Pediatr Crit Care Med. 2003;4:279-283.
13. Hon KL, Leung CW, Cheng WT, et al. Clinical presentations and outcome of severe acute respiratory syndrome in children Lancet 2003;361:1701-1703.
14. Ng PC, Leung CW, Chiu WK, Wong SF, Hon EK. SARS in newborns and children. Biol Neonate. 2004;85:293-298.
15. Shek CC, Ng PC, Fung GP, et al. Infants born to mothers with severe acute respiratory syndrome. Pediatrics. 2003;112:e254.
16. Babyn PS, Chu WC, Tsou IY, et al. Severe acute respiratory syndrome (SARS): chest radiographic features in children. Pediatr Radiol. 2004; 34:47-58.
17. Ng EK, Ng PC, Hon KL, et al. Serial analysis of the plasma concentration of SARS coronavirus RNA in pediatric patients with severe acute respiratory syndrome. Clin Chem. 2003;49:2085-2088.
18. Ng PC, Lam CW, Li AM, et al. Inflammatory cytokine profile in children with severe acute respiratory syndrome. Pediatrics. 2004;113: e7-14.
19. Subbarao K, McAuliffe J, Vogel L, et al. Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice. J Virol. 2004;78:3572-3577.
20. Cox E, Pensaert MB, Callebaut P. Intestinal protection against challenge with transmissible gastroenteritis virus of pigs immune after infection with the porcine respiratory coronavirus. Vaccine. 1993;11:267-272.
21. Enjuanes L, Smerdou C, Castilla J, et al. Development of protection against coronavirus induced diseases: a review. Adv Exp Med Biol. 1995;380:197-211.
22. Glansbeek HL, Haagmans BL, te Lintelo EG, et al. Adverse effects of feline IL-12 during DNA vaccination against feline infectious peritonitis virus. J Gen Virol. 2002;83:1-10.
23. Buchholz UJ, Bukreyev A, Yang L, et al. Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity. Proc Natl Acad Sci USA. 2004;101:9804-9809.
24. Bukreyev A, Lamirande EW, Buchholz UJ, et al. Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS. Lancet. 2004;363:2122-2127.
25. Snijder EJ, Bredenbeek PJ, Dobbe JC, et al. Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage. J Mol Biol. 2003;331:991-1004.
26. Guan Y, Zheng BJ, He YQ, et al. Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science. 2003;302:276-278.
27. He JF, Peng GW, Min J, et al. Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China. Science. 2004;303:1666-1669.
28. Fouchier RA, Kuiken T, Schutten M, et al. Aetiology: Koch's postulates fulfilled for SARS virus. Nature. 2003;423:240.
29. Martina BE, Haagmans BL, Kuiken T, et al. Virology: SARS virus infection of cats and ferrets. Nature. 2003;425:915.
30. Baric RS, Fu K, Chen W, Yount B. High recombination and mutation rates in mouse hepatitis virus suggest that coronaviruses may be potentially important emerging viruses. Adv Exp Med Biol. 1995;380:571-576.
31. Baric RS, Sullivan E, Hensley L, Yount B, Chen W. Persistent infection promotes cross-species transmissibility of mouse hepatitis virus. J Virol. 1999;73:638-649.
32. Baric RS, Yount B, Hensley L, Peel SA, Chen W. Episodic evolution mediates interspecies transfer of a murine coronavirus. J Virol. 1997; 71:1946-1955.
33. Li W, Moore MJ, Vasilieva N, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003;426: 450-454.
34. Olsen CW. A review of feline infectious peritonitis virus: molecular biology, immunopathogenesis, clinical aspects, and vaccination. Vet Microbiol. 1993;36:1-37.
35. Bisht H, Roberts A, Vogel L, et al. Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice. Proc Natl Acad Sci USA. 2004;101:6641-6646.
36. ter Meulen J, Bakker AB, van den Brink EN, et al. Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets. Lancet. 2004;363:2139-2141.
37. Thiel V, Ivanov KA, Putics A, et al. Mechanisms and enzymes involved in SARS coronavirus genome expression. J Gen Virol. 2003;84:2305-2315.
38. Yang ZY, Kong WP, Huang Y, A. et al. A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice. Nature. 2004;428:561-564.
39. Gao W, Tamin A, Soloff A, et al. Effects of a SARS-associated coronavirus vaccine in monkeys. Lancet. 2003;362:1895-1896.
40. World Health Organization. Investigation into China's recent SARS outbreak yields important lessons for global public health. July 2, 2004. Available at: http://www.wpro.who.int/sars/docs/update/update_7022004. asp. Accessed August 13, 2004.
41. Yount B, Curtis KM, Fritz EA, et al. Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus. Proc Natl Acad Sci USA. 2003;100:12995-13000.
42. Yount B, Denison MR, Weiss SR, Baric RS. Systematic assembly of a full-length infectious cDNA of mouse hepatitis virus strain A59. J Virol. 2002;76:11065-11078.
43. Denison MR, Yount B, Brockway SM, et al. Cleavage between replicase proteins p28 and p65 of mouse hepatitis virus is not required for virus replication. J Virol. 2004;78:5957-5965.